Clinical trialNCT00702325CompletedPhase 4Interventional

Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans

SponsorAstraZenecaEnrollment311Asthma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Tomas LG Andersson
AstraZeneca
Study Director
clinicaltrials.gov ↗
Ubaldo Martin, MD
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

57 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Pell City, Alabama, United States
Research Site
Bentonville, Arkansas, United States
Research Site
Hot Springs, Arkansas, United States
Research Site
Little Rock, Arkansas, United States
Research Site
Malvern, Arkansas, United States
Research Site
Huntington Park, California, United States
Research Site
Long Beach, California, United States
Research Site
Los Angeles, California, United States
Research Site
Los Angles, California, United States
Research Site
Orange, California, United States
Research Site
Rolling Hills Estates, California, United States
Research Site
Centennial, Colorado, United States
Research Site
Colorado Springs, Colorado, United States
Research Site
Waterbury, Connecticut, United States
Research Site
Inverness, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Ocala, Florida, United States
Research Site
Tallahassee, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Alpharetta, Georgia, United States
Research Site
Atlanta, Georgia, United States
Research Site
Decatur, Georgia, United States
Research Site
Lawrenceville, Georgia, United States
Research Site
Lithia Springs, Georgia, United States
Research Site
Lovejoy, Georgia, United States
Research Site
Chicago, Illinois, United States
Research Site
Hagerstown, Maryland, United States
Research Site
Lanham, Maryland, United States
Research Site
Largo, Maryland, United States
Research Site
Towson, Maryland, United States
Research Site
Flint, Michigan, United States
Research Site
Kansas City, Missouri, United States
Research Site
St Louis, Missouri, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Skillman, New Jersey, United States
Research Site
New York, New York, United States
Research Site
North Syracuse, New York, United States
Research Site
Durham, North Carolina, United States
Research Site
Greenville, North Carolina, United States
Research Site
Raleigh, North Carolina, United States

17 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2008
Primary completion: 30 Sept 2009
Completion: 30 Sept 2009
Last update posted: 9 Nov 2012
Registered enrollment: 311
Registry id: NCT00702325

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.